Crossref
Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence
AI in Precision Oncology · 2024
DOI: 10.1089/aipo.2023.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift AI in Precision Oncology, 2024. Verfasst von Michael C. Montalto. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Montalto, M. C. (2024). Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence. AI in Precision Oncology. https://doi.org/10.1089/aipo.2023.0003
Vancouver
Montalto MC. Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence. AI in Precision Oncology. 2024. doi:10.1089/aipo.2023.0003
BibTeX
@article{Montalto2024,
author = {Montalto, Michael C.},
title = {Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial Intelligence},
journal = {AI in Precision Oncology},
year = {2024},
doi = {10.1089/aipo.2023.0003}
}
EUVIMED